bw a1433u has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, S; Ganote, CE | 1 |
| Hill, RJ; Magee, W; Masamune, H; Oleynek, JJ; Tracey, WR | 1 |
2 other study(ies) available for bw a1433u and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C.
Topics: Animals; In Vitro Techniques; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naphthalenes; Protein Kinase C; Purinergic P1 Receptor Antagonists; Rabbits; Theophylline; Xanthines | 1995 |
Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.
Topics: Adenosine; Adenylyl Cyclases; Animals; Anti-Arrhythmia Agents; Binding, Competitive; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channels; Rabbits; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines | 1998 |